Good afternoon :)
Switch to
Place Order

Panacea Biotec Ltd

PANACEABIO
Health CareBiotechnology
SmallcapWith a market cap of ₹1,843 cr, stock is ranked 758
High RiskStock is 3.74x as volatile as Nifty
303.552.65 (+0.88%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CareBiotechnology
SmallcapWith a market cap of ₹1,843 cr, stock is ranked 758
High RiskStock is 3.74x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
-12.48
PB RatioPB Ratio
-7.95
Dividend YieldDiv. Yield
Sector PESector PE
41.00
Sector PBSector PB
5.48
Sector Div YldSctr Div Yld
0.63%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Panacea Biotec Limited is a health management company. The Company's principal business activity is the manufacture of allopathic pharmaceuticals preparations.

Investor PresentationView older 

Aug 2, 2021

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

2018201920202021600.78795.34574.08634.86-73.9937.73-194.26-147.69
Revenue
Profit
Loss
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

High Pledged Promoter Holding
Lower pledged promoter holdings is considered better

A significant proportion of promoter holdings is pledged

Decreased Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has decreased by 1.27%

See detailed holdings

Recent EventsAll events 

Certificate under SEBI (Depositories and Participants) Regulations, 2018 
Announced OnSep 10, 2021

Panacea Biotec Limited has informed the Exchange about dematerialisation of shares during the month of August, 2021 under SEBI (Depositories and Participants) Regulations, 2018 | Download

Panacea Biotec Limited has informed the Exchange about dematerialisation of shares during the month of August, 2021 under SEBI (Depositories and Participants) Regulations, 2018 | Download

Press Release 
Announced OnSep 6, 2021

Panacea Biotec Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India". | Download

Panacea Biotec Limited has informed the Exchange regarding a press release dated September 06, 2021, titled "Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India". | Download

Cash Dividend 
Ex. DateSep 19, 2011

Final • Div/Share: ₹ 0.75

See all events